TY - JOUR
T1 - An expert spotlight on inferior vena cava filters
AU - Pillai, Anil
AU - Kathuria, Manoj
AU - Bayona Molano, Maria del Pilar d
AU - Sutphin, Patrick
AU - Kalva, Sanjeeva P.
N1 - Publisher Copyright:
© 2021 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2021
Y1 - 2021
N2 - Introduction: Inferior vena cava (IVC) filters are mechanical filtration devices designed as an alternative to surgical ligation/plication of the IVC. Their use has been controversial, especially with the introduction of retrievable filters and expanded/prophylactic indications. Areas covered: Authors discuss the types of available IVC filters, indications for placement, evidence on their effectiveness in general and specific patient populations, procedural considerations, off-label use, complications, and filter retrieval. This review is based on manuscripts/abstracts published from 1960 to 2021 on venous thromboembolism and IVC filters. Expert opinion: Despite the limited data on their effectiveness and survival benefit, IVC filters continue to play an important role in the treatment of patients with venous thromboembolism (VTE) who cannot receive standard anticoagulation. There is no role of IVC filters in patients without VTE. While retrievable filters are desirable for short-term use, a dedicated team-based approach, and advanced training are required for their successful removal. Newer devices are promising in improving patient safety. The device manufacturers and regulatory agencies should consider specific approaches to track device-related adverse events. Population-based studies are required to establish optimal patient population who would benefit from these devices.
AB - Introduction: Inferior vena cava (IVC) filters are mechanical filtration devices designed as an alternative to surgical ligation/plication of the IVC. Their use has been controversial, especially with the introduction of retrievable filters and expanded/prophylactic indications. Areas covered: Authors discuss the types of available IVC filters, indications for placement, evidence on their effectiveness in general and specific patient populations, procedural considerations, off-label use, complications, and filter retrieval. This review is based on manuscripts/abstracts published from 1960 to 2021 on venous thromboembolism and IVC filters. Expert opinion: Despite the limited data on their effectiveness and survival benefit, IVC filters continue to play an important role in the treatment of patients with venous thromboembolism (VTE) who cannot receive standard anticoagulation. There is no role of IVC filters in patients without VTE. While retrievable filters are desirable for short-term use, a dedicated team-based approach, and advanced training are required for their successful removal. Newer devices are promising in improving patient safety. The device manufacturers and regulatory agencies should consider specific approaches to track device-related adverse events. Population-based studies are required to establish optimal patient population who would benefit from these devices.
KW - Venous thromboembolism
KW - deep venous thrombosis
KW - inferior vena cava filters
KW - pulmonary embolism
KW - retrievable filters
UR - http://www.scopus.com/inward/record.url?scp=85108372952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108372952&partnerID=8YFLogxK
U2 - 10.1080/17474086.2021.1943350
DO - 10.1080/17474086.2021.1943350
M3 - Review article
C2 - 34139952
AN - SCOPUS:85108372952
SN - 1747-4086
VL - 14
SP - 593
EP - 605
JO - Expert Review of Hematology
JF - Expert Review of Hematology
IS - 7
ER -